Status: Finalised First registered on: 05/05/2018
Last updated on: 28/02/2019
1. Study identification
EU PAS Register NumberEUPAS23879
Official titleUse of degarelix among patients with prostate cancer in daily practice
Study title acronymnone
Study typeObservational study
Brief description of the studyA population-based cohort study will be carried out using the UK’s general practitioner database, Optimum Patient Care Research Database (OPCRD), which includes prostate cancer patients initiating treatment of degarelix, leuprorelin, goserelin or triptorelin from 2010 till present. In this study, we will describe the characteristics, cardio events and urinary tract infections among patients with prostate cancer using degarelix, leuprorelin, goserelin or triptorelin in UK’s primary care.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsOPRI Pte Ltd
Department/Research groupObservational and Pragmatic Research Institute Pte Ltd
Organisation/affiliationOPRI Pte Ltd
Website/Homepagewww.opri.sg
Details of (Primary) lead investigator
Title Professor
Last name Price
First name David
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)

Countries in which this study is being conducted
National study

United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed01/02/201801/02/2018
Start date of data collection20/03/201820/03/2018
Start date of data analysis30/04/201808/05/2018
Date of interim report, if expected
Date of final study report31/05/201822/05/2018
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherHarvey Walsh100
5. Contact details for enquiries
Scientific Enquiries
Title Professor
Last name Price
First name David
Address line 15a Coles Lane
Address line 2Oakington 
Address line 3 
CityCambridge 
PostcodeCB24 3BA 
CountryUnited Kingdom
Phone number (incl. country code)441223967582 
Alternative phone number 
Fax number (incl. country code) 
Email address dprice@opri.sg
Public Enquiries
Title Professor 
Last name Price 
First name David 
Address line 15a Coles Lane 
Address line 2Oakington 
Address line 3 
CityCambridge 
PostcodeCB24 3BA 
CountryUnited Kingdom 
Phone number (incl. country code)441223967582 
Alternative phone number 
Fax number (incl. country code) 
Email address dprice@opri.sg 
Top